Tevogen Inc. Earnings Per Share (Diluted)
Tevogen Inc. (TVGN) reported Earnings Per Share (Diluted) of -$1.52 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- Tevogen Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$1.52.
- Tevogen Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$1.61.
- Tevogen Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $0.01, a 56.25% decline year-over-year.
- Tevogen Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.03.
- Tevogen Inc. earnings per share, diluted for fiscal 2025 was -$8.08.
- Tevogen Inc. earnings per share, diluted for fiscal 2024 was -$3.50.
- Tevogen Inc. earnings per share, diluted for fiscal 2023 was -$2.44.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.52 10-Q · filed 2026-08-14 | -$3.16 10-Q · filed 2026-08-14 | $0.09 derived: net income ÷ weighted average shares · filed 2026-08-14 | $0.26 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2026-03-31 | -$1.61 10-Q · filed 2026-05-15 | $0.04 derived: net income ÷ weighted average shares · filed 2026-05-15 | $0.14 derived: net income ÷ weighted average shares · filed 2026-05-15 | $0.25 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2025-12-31 | $0.01 derived: net income ÷ weighted average shares · filed 2026-03-31 | $0.06 derived: net income ÷ weighted average shares · filed 2026-03-31 | $0.14 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$8.08 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$0.03 10-Q · filed 2025-11-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.12 10-Q · filed 2025-11-14 | $0.47 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2025-06-30 | -$1.71 10-Q · filed 2026-08-14 | -$0.03 10-Q · filed 2025-08-14 | -$4.95 10-Q · filed 2026-08-14 | -$0.09 10-Q · filed 2025-08-14 | $0.17 derived: net income ÷ weighted average shares · filed 2026-08-14 | $0.43 derived: net income ÷ weighted average shares · filed 2026-08-14 | |
| 2025-03-31 | -$3.25 10-Q · filed 2026-05-15 | -$0.07 10-Q · filed 2025-05-14 | $0.09 derived: net income ÷ weighted average shares · filed 2026-05-15 | $0.26 derived: net income ÷ weighted average shares · filed 2026-05-15 | $0.91 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2024-12-31 | $0.02 derived: net income ÷ weighted average shares · filed 2026-03-31 | $0.10 derived: net income ÷ weighted average shares · filed 2026-03-31 | $0.45 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$3.50 10-K · filed 2026-03-31 | -$0.07 10-K · filed 2025-04-02 | ||
| 2024-09-30 | -$0.03 10-Q · filed 2025-11-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$0.01 10-Q · filed 2025-11-14 | -$0.43 derived: net income ÷ weighted average shares · filed 2025-11-14 | |||
| 2024-06-30 | -$0.04 10-Q · filed 2025-08-14 | -$0.29 10-Q · filed 2025-08-14 | -$0.44 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$0.46 derived: net income ÷ weighted average shares · filed 2025-08-14 | |||
| 2024-03-31 | -$0.26 10-Q · filed 2025-05-14 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.47 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.66 derived: net income ÷ weighted average shares · filed 2025-05-14 | |||
| 2023-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2025-04-02 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-04-02 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-04-02 | -$2.44 10-K · filed 2025-04-02 | |||
| 2023-09-30 | -$0.03 10-Q · filed 2024-11-19 | -$0.22 derived: net income ÷ weighted average shares · filed 2024-11-19 | -$2.30 10-Q · filed 2024-11-19 | ||||
| 2023-06-30 | -$0.18 10-Q · filed 2024-08-14 | -$0.44 10-Q · filed 2024-08-14 | |||||
| 2023-03-31 | -$0.26 10-Q · filed 2024-05-28 | ||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |